Biotech is strong again. Funds that invest in biotechnology and 
pharmaceutical companies were the clear winners in the second quarter.

FUND                            ------TOTAL RETURNS*------    ASSETS   CURRENCY
                                2ND QTR.  12 MOS.    5 YRS.  MILLIONS

OPPENHEIM PHARMA/WHEALTH         22.96     87.88     29.53      386      USD
PICTET G.S.F. BIOTECH            21.94    173.16     39.49      838      USD
FORTIS L EQ PHARMA WORLD C       17.94     30.23                366      EUR
INVESCO GT HEALTHCARE A          16.52      9.56     21.48      351      USD
BBL (L) INV HEALTHCARE C         16.22     12.01                186      USD
SEB LUX (F)-LAKEMEDELS-OCH BIO   15.80     48.17     26.39      204      USD
KB LUX EQUITY FD GLBL PHARMA     15.45     16.88                109      USD
APOAESCULAP                      15.01     33.84     20.29      146      EUR
DEKATEAM PHARMA TECH TF          14.90     29.47               1127      EUR
UBS (LUX) EF-BIOTECH             14.74     96.52               1099      USD
UBS (LUX) EF-HEALTH CARE         14.56     12.04                214      USD
DEKATEAM IMMOFLEX USA            13.81      5.89                 74      EUR
ACM INTL HEALTH CARE PTFL AX     12.35     21.48     18.50      477      USD
LAZARD JAPAN                     11.82     33.62      0.36       32      USD
FLEMING F US DISCOVERY           11.21     14.90     14.53      229      USD
SEB LUX (F)-TEKNOLOGIFOND         9.07    106.08     37.39      208      USD
COMGEST EUROPE                    7.96     14.92     15.82      285      CHF
FLEMING F AMER FLEDGELING         7.90     21.36     17.20      303      USD
UBS (LUX) EF-SMALL CAPS USA       7.90     78.89     23.49      155      USD
UBS (LUX) EF-AUSTRALIA            7.77      2.28      8.30      249      AUD


* In U.S. dollars, includes dividends and capital gains.
Currency codes: AUD= Australian dollar; CHF=Swiss franc; EUR=euro; USD= U.S. 
dollar.

DATA: STANDARD & POOR'S MICROPAL